The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
This book since first published in 2004 has been a major resource providing insights and practical guidance for the CMC teams to develop an acceptable cost-effective, risk-based CMC regulatory compliance strategy for biopharmaceuticals (recombinant proteins, monoclonal antibodies, genetically engine...
Κύριος συγγραφέας: | Geigert, John (Συγγραφέας, http://id.loc.gov/vocabulary/relators/aut) |
---|---|
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Έκδοση: | 3rd ed. 2019. |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions Current and Future Trends /
Έκδοση: (2019) -
Drug Transporters in Drug Disposition, Effects and Toxicity
Έκδοση: (2019) -
Novel Drug Delivery Technologies Innovative Strategies for Drug Re-positioning /
Έκδοση: (2019) -
Nutraceuticals in Veterinary Medicine
Έκδοση: (2019) -
Zebrafish: A Model for Marine Peptide Based Drug Screening
ανά: Ramachandran, Saravanan, κ.ά.
Έκδοση: (2019)